text.skipToContent text.skipToNavigation

Maximum quantity allowed is 999

Please select the quantity

CAS RN: 66852-54-8 | Product Number: H1457

Halobetasol Propionate


Purity: >98.0%(HPLC)
Synonyms:
  • 21-Chloro-6α,9α-difluoro-11β,17α-dihydroxy-16β-methyl-1,4-pregnadiene-3,20-dione 17-Propionate
Documents:
25MG
€57.00
3   20  
100MG
€188.00
1   16  

*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).


Product Number H1457
Purity / Analysis Method >98.0%(HPLC)
Molecular Formula / Molecular Weight C__2__5H__3__1ClF__2O__5 = 484.96 
Physical State (20 deg.C) Solid
Storage Temperature 0-10°C
Condition to Avoid Heat Sensitive
CAS RN 66852-54-8
Reaxys Registry Number 11109992
MDL Number

MFCD00866013

Specifications
Appearance White to Almost white powder to crystal
Purity(HPLC) min. 98.0 area%
Specific rotation [a]20/D +89.0 to +93.0 deg(C=1, Dioxane)
Properties (reference)
Melting Point 221 °C
Specific Rotation 91° (C=1,Dioxane)
GHS
Pictogram Pictogram
Signal Word Warning
Hazard Statements H315 : Causes skin irritation.
H319 : Causes serious eye irritation.
Precautionary Statements P264 : Wash skin thoroughly after handling.
P280 : Wear protective gloves/ eye protection/ face protection.
P302 + P352 : IF ON SKIN: Wash with plenty of water.
P337 + P313 : If eye irritation persists: Get medical advice/ attention.
P362 + P364 : Take off contaminated clothing and wash it before reuse.
P332 + P313 : If skin irritation occurs: Get medical advice/ attention.
Related Laws:
RTECS# TU3723500
Transport Information:
HS Number 2937230000
Application
Halobetasol propionate: A Super-Potent Corticosteroid

Halobetasol propionate is a super-potent corticosteroid with additional fluorine at the 6α position when compared with clobetasol 17-propionate [C2612]. The additional fluorine in the 6α position further increases its topical anti-inflammatory and antiproliferative activities. In addition, an ointment formulation in combination of halobetasol propionate and fusidic acid [F1007] for treatment of dermal conditions have been reported. (The product is for research purpose only.)

References


TCIMAIL
Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.

The requested SDS is not available.

Please Contact Us for more information.

Specifications
C of A & Other Certificates
Please enter Lot Number Incorrect Lot Number is entered
Analytical Charts
Please enter Lot Number Incorrect Lot Number is entered

The requested analytical chart is not available. Sorry for the inconvenience.

Other Documents